EP0380558A4 - Liposomal nucleoside analogues for treating aids - Google Patents
Liposomal nucleoside analogues for treating aidsInfo
- Publication number
- EP0380558A4 EP0380558A4 EP19880908811 EP88908811A EP0380558A4 EP 0380558 A4 EP0380558 A4 EP 0380558A4 EP 19880908811 EP19880908811 EP 19880908811 EP 88908811 A EP88908811 A EP 88908811A EP 0380558 A4 EP0380558 A4 EP 0380558A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- liposomal
- nucleoside analogues
- treating aids
- aids
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9975587A | 1987-09-22 | 1987-09-22 | |
US99755 | 1993-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0380558A1 EP0380558A1 (en) | 1990-08-08 |
EP0380558A4 true EP0380558A4 (en) | 1991-07-31 |
Family
ID=22276457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19880908811 Ceased EP0380558A4 (en) | 1987-09-22 | 1988-09-19 | Liposomal nucleoside analogues for treating aids |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0380558A4 (en) |
JP (1) | JPH03501253A (en) |
AU (1) | AU2526188A (en) |
WO (1) | WO1989002733A1 (en) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6448392B1 (en) | 1985-03-06 | 2002-09-10 | Chimerix, Inc. | Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use |
US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
US6599887B2 (en) | 1988-07-07 | 2003-07-29 | Chimerix, Inc. | Methods of treating viral infections using antiviral liponucleotides |
US5817638A (en) * | 1988-07-07 | 1998-10-06 | Nexstar Pharmaceuticals, Inc. | Antiviral liponucleosides: treatment of hepatitis B |
US6252060B1 (en) | 1988-07-07 | 2001-06-26 | Nexstar Pharmaceuticals, Inc. | Antiviral liponucleosides: treatment of hepatitis B |
ZA902710B (en) * | 1989-05-22 | 1991-12-24 | Univ Georgia Res Found | Enzyme luminescence assay |
DE3916595A1 (en) * | 1989-05-22 | 1990-11-29 | Boehringer Mannheim Gmbh | METHOD FOR NON-RADIOACTIVE MEASURING OF NUCLEIC ACID SYNTHESIS IN EUKARYONTIC CELLS |
US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
US5463092A (en) * | 1989-11-22 | 1995-10-31 | Vestar, Inc. | Lipid derivatives of phosphonacids for liposomal incorporation and method of use |
CA2045601A1 (en) * | 1989-12-08 | 1991-06-09 | Kevin J. Scanlon | Circumvention of human tumor drug resistance |
US5817646A (en) * | 1991-11-15 | 1998-10-06 | Laboratoires Inocosm | Polar lipid composition of plant origin |
FR2683721B1 (en) * | 1991-11-15 | 1995-06-09 | Inocosm Laboratoires | POLAR LIPID COMPOSITION FOR VEHICULATING AN ACTIVE AGENT AND / OR PENETRATING IT INTO A TARGET CELL. |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
AU722214B2 (en) | 1995-06-07 | 2000-07-27 | Centre National De La Recherche Scientifique (Cnrs) | Nucleosides with anti-hepatitis B virus activity |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
BR9908270A (en) | 1998-02-25 | 2004-06-29 | Univ Emory | 2-Fluoro-nucleosides, pharmaceutical compositions and their uses |
ES2579903T3 (en) | 1998-08-10 | 2016-08-17 | Centre National De La Recherche Scientifique (Cnrs) | Beta-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
EP1382343B1 (en) | 1998-11-02 | 2010-02-17 | Gilead Sciences, Inc. | Combination therapy to treat hepatitis B virus |
EP1207907B1 (en) * | 1999-08-13 | 2004-11-03 | University Of Maryland Biotechnology Institute | Compositions for treating viral infections, and methods therefor |
EP1284720B1 (en) | 2000-03-29 | 2006-09-13 | Georgetown University | L-fmau for the treatment of hepatitis delta viral infection |
US6761901B1 (en) | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
US6787526B1 (en) | 2000-05-26 | 2004-09-07 | Idenix Pharmaceuticals, Inc. | Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides |
US6875751B2 (en) | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
US6689760B1 (en) | 2000-07-10 | 2004-02-10 | Enzrel Inc. | Anti-mycobacterial compositions |
US6455073B1 (en) | 2000-07-10 | 2002-09-24 | Enzrel, Inc. | Covalent microparticle-drug conjugates for biological targeting |
CN1646141B (en) | 2000-10-18 | 2014-06-25 | 吉利德制药有限责任公司 | Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
AU2002335489B2 (en) | 2001-03-01 | 2008-06-05 | Abbott Laboratories | Polymorphic and other crystalline forms of cis-FTC |
AU2002330154A1 (en) | 2001-09-28 | 2003-04-07 | Centre National De La Recherche Scientifique | Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
JP2005523249A (en) | 2002-01-09 | 2005-08-04 | エンズレル インコーポレイテッド | Liposomal drug delivery of polycyclic aromatic antioxidants or anti-inflammatory compounds |
WO2004002999A2 (en) | 2002-06-28 | 2004-01-08 | Idenix (Cayman) Limited | Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
AU2003248748A1 (en) | 2002-06-28 | 2004-01-19 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
TWI244393B (en) | 2002-08-06 | 2005-12-01 | Idenix Pharmaceuticals Inc | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
PT1572095E (en) | 2002-09-13 | 2015-10-13 | Novartis Ag | Beta-l-2'-deoxynucleosides for use in the treatment of resistant hbv strains |
KR20050088079A (en) | 2002-11-15 | 2005-09-01 | 이데닉스 (케이만) 리미티드 | 2'-branched nucleosides and flaviviridae mutation |
CA2734052A1 (en) | 2003-05-30 | 2005-01-13 | Pharmasset, Inc. | Modified fluorinated nucleoside analogues |
PL1658302T3 (en) | 2003-07-25 | 2011-03-31 | Idenix Pharmaceuticals Inc | Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c |
ES2629682T3 (en) | 2004-03-29 | 2017-08-14 | University Of South Florida | Effective treatment of tumors and cancer with triciribin phosphate |
RU2433124C2 (en) | 2004-09-14 | 2011-11-10 | Фармассет, Инк. | Methods of producing 2'-fluoro-2'-alkyl-substituted or other substituted ribofuranosyl pyrimidines and purines and derivatives thereof |
CA2623522C (en) | 2005-09-26 | 2015-12-08 | Pharmasset, Inc. | Modified 4'-nucleosides as antiviral agents |
US8895531B2 (en) | 2006-03-23 | 2014-11-25 | Rfs Pharma Llc | 2′-fluoronucleoside phosphonates as antiviral agents |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
EP3042660A3 (en) | 2008-04-15 | 2016-10-26 | RFS Pharma, LLC. | Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
NZ593648A (en) | 2008-12-23 | 2013-09-27 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
CL2009002206A1 (en) | 2008-12-23 | 2011-08-26 | Gilead Pharmasset Llc | Compounds derived from pyrrolo - (2-3-d] -pyrimidin-7 (6h) -tetrahydrofuran-2-yl phosphonamidate, pharmaceutical composition; and its use in the treatment of viral diseases. |
EA201100851A1 (en) | 2008-12-23 | 2012-04-30 | Фармассет, Инк. | NUCLEOSIDE ANALOGUES |
TWI576352B (en) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | Nucleoside phosphoramidates |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
BR112012024884A2 (en) | 2010-03-31 | 2016-10-18 | Gilead Pharmasset Llc | stereo-selective synthesis of phosphorus-containing assets |
AR084044A1 (en) | 2010-11-30 | 2013-04-17 | Pharmasset Inc | 2’-ESPIRO-NUCLEOSID COMPOUNDS |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
US9089574B2 (en) | 2011-11-30 | 2015-07-28 | Emory University | Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections |
ES2792503T3 (en) | 2013-08-27 | 2020-11-11 | Gilead Pharmasset Llc | Combined formulation of two antiviral compounds |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0114577A1 (en) * | 1983-01-21 | 1984-08-01 | MAGIS FARMACEUTICI S.p.A. | New pharmaceutical composition |
EP0152379A2 (en) * | 1984-02-15 | 1985-08-21 | Ciba-Geigy Ag | Process for preparing pharmaceutical compositions containing unilamellar liposomes |
EP0216511A2 (en) * | 1985-08-26 | 1987-04-01 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine |
EP0267050A2 (en) * | 1986-11-06 | 1988-05-11 | Research Development Foundation | Aerosols containg liposomes and method for their preparation. |
NL8700089A (en) * | 1987-01-15 | 1988-08-01 | Stichting Rega V Z W | Medicaments for treating AIDS - contg. 2',3'-di:deoxy-thymidine or 2',3'-di:deoxy-thymidinene |
WO1988005657A1 (en) * | 1987-01-28 | 1988-08-11 | Chu Chung K | 3'-azido-2',3'-dideoxyuridine anti-retroviral composition |
EP0286418A1 (en) * | 1987-04-10 | 1988-10-12 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Anti-retroviral agents and delivery systems for the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4291024A (en) * | 1978-04-10 | 1981-09-22 | Turcotte Joseph G | Cytotoxic liponucleotide analogs |
ZA833446B (en) * | 1982-05-28 | 1984-02-29 | Solco Basel Ag | Process for the preparation of cell-and tissue-regenerating substances |
US4704357A (en) * | 1985-09-30 | 1987-11-03 | United States Of America As Represented By The Department Of Health And Human Services | Immortalized T-lymphocyte cell line for testing HTLV-III inactivation |
-
1988
- 1988-09-19 JP JP63508005A patent/JPH03501253A/en active Pending
- 1988-09-19 AU AU25261/88A patent/AU2526188A/en not_active Abandoned
- 1988-09-19 EP EP19880908811 patent/EP0380558A4/en not_active Ceased
- 1988-09-19 WO PCT/US1988/003210 patent/WO1989002733A1/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0114577A1 (en) * | 1983-01-21 | 1984-08-01 | MAGIS FARMACEUTICI S.p.A. | New pharmaceutical composition |
EP0152379A2 (en) * | 1984-02-15 | 1985-08-21 | Ciba-Geigy Ag | Process for preparing pharmaceutical compositions containing unilamellar liposomes |
EP0216511A2 (en) * | 1985-08-26 | 1987-04-01 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine |
EP0267050A2 (en) * | 1986-11-06 | 1988-05-11 | Research Development Foundation | Aerosols containg liposomes and method for their preparation. |
NL8700089A (en) * | 1987-01-15 | 1988-08-01 | Stichting Rega V Z W | Medicaments for treating AIDS - contg. 2',3'-di:deoxy-thymidine or 2',3'-di:deoxy-thymidinene |
WO1988005657A1 (en) * | 1987-01-28 | 1988-08-11 | Chu Chung K | 3'-azido-2',3'-dideoxyuridine anti-retroviral composition |
EP0286418A1 (en) * | 1987-04-10 | 1988-10-12 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Anti-retroviral agents and delivery systems for the same |
Non-Patent Citations (1)
Title |
---|
See also references of WO8902733A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0380558A1 (en) | 1990-08-08 |
WO1989002733A1 (en) | 1989-04-06 |
AU2526188A (en) | 1989-04-18 |
JPH03501253A (en) | 1991-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0380558A4 (en) | Liposomal nucleoside analogues for treating aids | |
EP0301414B1 (en) | Surface active hydroxysulfonates | |
JPS6468373A (en) | Therapeutical nucleoside | |
PH29943A (en) | Therapeutic nucleosides | |
EP0375726A4 (en) | Melatonin analogues | |
EP0286425A3 (en) | Therapeutic nucleosides | |
ZA876673B (en) | Nucleoside analogues | |
PH25577A (en) | Purine derivatives | |
GB8827337D0 (en) | Nucleoside analogues | |
PH24812A (en) | Therapeutic nucleosides | |
GB8706176D0 (en) | Therapeutic nucleosides | |
GB8614733D0 (en) | Aids treatment | |
GB8712691D0 (en) | Therapeutic nucleosides | |
GB8725466D0 (en) | Purine derivatives | |
IE872385L (en) | Nucleoside analogues | |
GB8805832D0 (en) | Surface treatment | |
IE870520L (en) | Isohexide nucleoside | |
GB8713293D0 (en) | Massaging aid | |
GB8725179D0 (en) | Aids for disabled | |
GB8719401D0 (en) | Immobilization of fungal beta-galactosidase | |
GB8702795D0 (en) | Bath aids | |
GB8904162D0 (en) | Nucleoside analogues | |
GB8921457D0 (en) | Nucleoside analogues | |
GB8919507D0 (en) | Nucleoside analogues | |
IE871695L (en) | Azabicycloalka(e)ne derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19900319 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19910610 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19920221 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 19930513 |